Overview
Albemarle Corporation, based in the United States, is a global leader in the specialty chemicals industry, with a pronounced emphasis on lithium, bromine, and catalyst solutions. It primarily operates within the lithium sector, focusing on the production and development of lithium compounds which are crucial for rechargeable batteries used in electric vehicles and other technologies. Albemarle's strategic projects include expanding its lithium production capacity through the development of the Kemerton site in Australia and the La Negra site in Chile, responding to the skyrocketing demand for battery-grade lithium. This expansion is part of its broader strategy to maintain and strengthen its position in the rapidly evolving and increasingly competitive battery materials market.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Albemarle Corporation as of June 30, 2025 is 4,993.28 MM.
- The operating income for Albemarle Corporation as of June 30, 2025 is -183.89 MM.
- The net income for Albemarle Corporation as of June 30, 2025 is -929.45 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 4,993.28 | -183.89 | -929.45 |
2025-03-31 | 5,093.67 | -435.05 | -1,140.55 |
2024-12-31 | 5,377.53 | -597.75 | -1,179.45 |
2024-09-30 | 6,501.98 | -1,503.26 | -1,872.42 |
2024-06-30 | 7,457.88 | -1,351.18 | -500.90 |
2024-03-31 | 8,397.69 | -782.09 | 337.34 |
2023-12-31 | 9,617.20 | 467.11 | 1,573.48 |
2023-09-30 | 9,882.02 | 2,237.70 | 3,323.60 |
2023-06-30 | 9,663.23 | 3,270.48 | 3,918.28 |
2023-03-31 | 8,772.63 | 3,346.25 | 3,675.01 |
2022-12-31 | 7,320.10 | 2,566.66 | 2,689.82 |
2022-09-30 | 5,593.33 | 1,866.89 | 1,553.55 |
2022-06-30 | 4,332.09 | 1,102.12 | 263.55 |
2022-03-31 | 3,626.39 | 775.06 | 281.38 |
2021-12-31 | 3,327.96 | 621.13 | 123.67 |
2021-09-30 | 3,312.90 | 521.21 | 212.13 |
2021-06-30 | 3,229.20 | 536.40 | 703.21 |
2021-03-31 | 3,219.36 | 541.78 | 364.24 |
2020-12-31 | 3,128.91 | 510.47 | 375.76 |
2020-09-30 | 3,242.33 | 600.33 | 381.52 |
Income Statement: EPS
- The earnings per share basic for Albemarle Corporation as of June 30, 2025 is -9.32.
- The earnings per share diluted for Albemarle Corporation as of June 30, 2025 is -9.32.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -9.32 | -9.32 |
2025-03-31 | -11.12 | -11.12 |
2024-12-31 | -11.20 | -11.20 |
2024-09-30 | -16.75 | -16.74 |
2024-06-30 | -4.72 | -4.71 |
2024-03-31 | 2.78 | 2.77 |
2023-12-31 | 13.41 | 13.36 |
2023-09-30 | 28.34 | 28.21 |
2023-06-30 | 33.43 | 33.25 |
2023-03-31 | 31.37 | 31.19 |
2022-12-31 | 22.97 | 22.84 |
2022-09-30 | 13.27 | 13.19 |
2022-06-30 | 2.25 | 2.24 |
2022-03-31 | 2.41 | 2.39 |
2021-12-31 | 1.07 | 1.06 |
2021-09-30 | 1.87 | 1.87 |
2021-06-30 | 6.36 | 6.32 |
2021-03-31 | 3.37 | 3.35 |
2020-12-31 | 3.53 | 3.52 |
2020-09-30 | 3.59 | 3.59 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Albemarle Corporation as of June 30, 2025 is 775.10 MM.
- The cash from investing activities for Albemarle Corporation as of June 30, 2025 is -451.65 MM.
- The cash from financing activities for Albemarle Corporation as of June 30, 2025 is -413.49 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 775.10 | -451.65 | -413.49 |
2025-03-31 | 1,149.50 | -1,259.24 | -435.57 |
2024-12-31 | 702.07 | -1,574.44 | 1,241.73 |
2024-09-30 | 607.48 | -2,306.82 | 1,731.62 |
2024-06-30 | 995.78 | -2,667.63 | 1,941.28 |
2024-03-31 | 702.29 | -2,736.66 | 2,299.89 |
2023-12-31 | 1,325.32 | -2,781.16 | 623.91 |
2023-09-30 | 2,375.79 | -2,324.97 | -72.46 |
2023-06-30 | 2,642.22 | -1,975.38 | -237.43 |
2023-03-31 | 2,422.65 | -1,733.56 | 435.59 |
2022-12-31 | 1,907.85 | -1,422.65 | 611.89 |
2022-09-30 | 809.27 | -1,121.07 | 1,219.90 |
2022-06-30 | 18.71 | -1,064.38 | 1,221.28 |
2022-03-31 | 392.48 | -719.96 | 251.08 |
2021-12-31 | 344.26 | -666.59 | 50.21 |
2021-09-30 | 827.79 | -578.88 | -360.37 |
2021-06-30 | 976.85 | -525.20 | -392.32 |
2021-03-31 | 801.81 | -803.43 | -17.00 |
2020-12-31 | 798.91 | -863.57 | 177.26 |
2020-09-30 | 835.45 | -1,707.65 | 1,266.64 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Management Effectiveness
- The roa for Albemarle Corporation as of June 30, 2025 is -0.06.
- The roe for Albemarle Corporation as of June 30, 2025 is -0.08.
- The roic for Albemarle Corporation as of June 30, 2025 is -0.08.
- The croic for Albemarle Corporation as of June 30, 2025 is -0.04.
- The ocroic for Albemarle Corporation as of June 30, 2025 is 0.08.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.06 | -0.08 | -0.08 | -0.04 | 0.08 |
2025-03-31 | -0.06 | -0.10 | -0.08 | -0.04 | 0.08 |
2024-12-31 | -0.10 | -0.18 | -0.13 | 0.00 | 0.04 |
2024-09-30 | -0.10 | -0.18 | -0.13 | 0.00 | 0.04 |
2024-06-30 | 0.02 | 0.04 | 0.02 | 0.03 | 0.05 |
2024-03-31 | 0.10 | 0.19 | 0.11 | -0.04 | 0.09 |
2023-12-31 | 0.24 | 0.48 | 0.24 | 0.02 | 0.17 |
2023-09-30 | 0.31 | 0.62 | 0.28 | 0.05 | 0.19 |
2023-06-30 | 0.31 | 0.62 | 0.28 | 0.05 | 0.19 |
2023-03-31 | 0.32 | 0.61 | 0.28 | 0.09 | 0.19 |
2022-12-31 | 0.14 | 0.26 | 0.15 | 0.08 | 0.08 |
2022-09-30 | 0.14 | 0.26 | 0.15 | 0.08 | 0.08 |
2022-06-30 | 0.02 | 0.04 | 0.03 | 0.01 | 0.00 |
2022-03-31 | 0.03 | 0.05 | 0.03 | -0.01 | 0.04 |
2021-12-31 | 0.01 | 0.03 | 0.01 | -0.04 | 0.04 |
2021-09-30 | 0.02 | 0.05 | 0.03 | -0.01 | 0.10 |
2021-06-30 | 0.07 | 0.17 | 0.07 | 0.01 | 0.10 |
2021-03-31 | 0.04 | 0.09 | 0.04 | 0.00 | 0.09 |
2020-12-31 | 0.04 | 0.09 | 0.05 | 0.02 | 0.10 |
2020-09-30 | 0.05 | 0.10 | 0.05 | 0.05 | 0.10 |
Gross Margins
- The gross margin for Albemarle Corporation as of June 30, 2025 is 0.04.
- The net margin for Albemarle Corporation as of June 30, 2025 is -0.22.
- The operating margin for Albemarle Corporation as of June 30, 2025 is -0.09.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.04 | -0.22 | -0.09 |
2025-03-31 | 0.04 | -0.22 | -0.09 |
2024-12-31 | -0.12 | -0.29 | -0.23 |
2024-09-30 | -0.12 | -0.29 | -0.23 |
2024-06-30 | -0.00 | 0.04 | -0.09 |
2024-03-31 | 0.12 | 0.16 | 0.05 |
2023-12-31 | 0.29 | 0.34 | 0.23 |
2023-09-30 | 0.40 | 0.41 | 0.34 |
2023-06-30 | 0.40 | 0.41 | 0.34 |
2023-03-31 | 0.45 | 0.42 | 0.38 |
2022-12-31 | 0.41 | 0.28 | 0.33 |
2022-09-30 | 0.41 | 0.28 | 0.33 |
2022-06-30 | 0.35 | 0.06 | 0.25 |
2022-03-31 | 0.33 | 0.08 | 0.21 |
2021-12-31 | 0.30 | 0.04 | 0.19 |
2021-09-30 | 0.31 | 0.06 | 0.17 |
2021-06-30 | 0.32 | 0.22 | 0.17 |
2021-03-31 | 0.32 | 0.11 | 0.17 |
2020-12-31 | 0.32 | 0.12 | 0.16 |
2020-09-30 | 0.33 | 0.12 | 0.19 |
Identifiers and Descriptors
Central Index Key (CIK) | 915913 |